To confirm that SLC30A3 expression is indeed dysregulated in Alzheimer’s disease, we established an AD cell model by treating SH-SY5Y cells with OKA. The gene discussed is SLC30A3; the disease is early-onset autosomal dominant Alzheimer disease.